Castleark Management LLC Clovis Oncology, Inc. Transaction History

Castleark Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $1.62 Million - $3.25 Million	-126,739 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $2.24 Million - $3.84 Million	126,739 New	126,739 $3.15 Million
Q4 2017 Feb 15, 2018	SELL	$57.69 - $84.58 $3.56 Million - $5.21 Million	-61,625 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $4.14 Million - $5.23 Million	61,625	61,625 $5.08 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.